90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies. (Record no. 12452277)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01167 a2200373 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514063009.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200305s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0006-3525 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1002/bip.10349 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Paganelli, G |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20030514 |
| 245 00 - TITLE STATEMENT | |
| Title | 90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Biopolymers |
| Date of publication, distribution, etc. | 2002 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 393-8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neuroendocrine Tumors |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Octreotide |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Radiopharmaceuticals |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Somatostatin |
| General subdivision | analogs & derivatives |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bodei, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Handkiewicz Junak, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rocca, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Papi, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lopera Sierra, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gatti, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chinol, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bartolomei, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fiorenza, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grana, C |
| 773 0# - HOST ITEM ENTRY | |
| Title | Biopolymers |
| Related parts | vol. 66 |
| -- | no. 6 |
| -- | p. 393-8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/bip.10349">https://doi.org/10.1002/bip.10349</a> |
| Public note | Available from publisher's website |
No items available.